Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
922
datasets available to search
ShareScore release 0.9.0
Dataset results
922 results for “Chronic lymphocytic leukemia”
Chemotherapy With Cordycepin Plus Pentostatin in Treating Patients With Refractory Acute Lymphocytic or Chronic Myelogenous Leukemia
ClinicalTrials.gov study NCT00003005. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Peripheral Stem Cell Transplantation Plus Combination Chemotherapy in Treating Patients With Low-Grade Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT00003402. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Acalabrutinib Safety Study in Untreated and Relapsed or Refractory Chronic Lymphocytic Leukemia Patients
ClinicalTrials.gov study NCT04008706. IPD Sharing: YES. Countries: 17. Publications: 0.
Combination Chemotherapy in Treating Patients With Chronic Lymphocytic Leukemia or Lymphocytic Lymphoma
ClinicalTrials.gov study NCT00045513. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1
ClinicalTrials.gov study NCT06136559. IPD Sharing: YES. Countries: 29. Publications: 0.
Study of XL228 in Subjects With Chronic Myeloid Leukemia or Philadelphia-Chromosome-Positive Acute Lymphocytic Leukemia
ClinicalTrials.gov study NCT00464113. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of the Safety and Pharmacokinetics of Escalating Doses of DCDT2980S in Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia And DCDT2980S in Comb
ClinicalTrials.gov study NCT01209130. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Modified Immune Cells (CD19/CD20 CAR-T Cells) in Treating Patients With Recurrent or Refractory B-Cell Lymphoma or Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT04007029. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Randomized Phase II Study Of Bruton Tyrosine Kinase Inhibitor With Or Without Venetoclax In Veterans With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
ClinicalTrials.gov study NCT06520098. IPD Sharing: NO. Countries: 1. Publications: 0.
Direct Measurement of Leukemic Cell Turnover (Synthesis and Removal) in Patients With Chronic Lymphocytic Leukemia (CLL) Using Deuterated Water
ClinicalTrials.gov study NCT01110850. IPD Sharing: Not stated. Countries: 1. Publications: 0.
High-Dose Chemotherapy Followed by Total-Body Irradiation and Peripheral Stem Cell Transplantation in Treating Patients With Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT00002788. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of Emavusertib + An Approved Bruton Tyrosine Kinase Inhibitor (BTKi) in Participants With Chronic Lymphocytic Leukemia (CLL) and Other B-cell Malignancies
ClinicalTrials.gov study NCT07271667. IPD Sharing: NO. Countries: 0. Publications: 0.
Study of Weekly Clofarabine for the Treatment of Relapsed/Refractory Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT00081887. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) in 17p- Chronic Lymphocytic Leukemia (CLL)
ClinicalTrials.gov study NCT01675102. IPD Sharing: Not stated. Countries: 7. Publications: 0.
Testing the Effectiveness of the Anti-cancer Drug, Mirdametinib, in Treating Relapsed, Refractory Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT07061951. IPD Sharing: YES. Countries: 1. Publications: 0.
Exercise As Intervention in Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT06396611. IPD Sharing: NO. Countries: 1. Publications: 0.
Lenalidomide, Ibrutinib, and Rituximab in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma That Is Metastatic or Cannot Be Removed by Surgery
ClinicalTrials.gov study NCT02160015. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Bryostatin 1 in Treating Patients With Relapsed Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT00002908. IPD Sharing: Not stated. Countries: 1. Publications: 0.
STop and Restart Acalabrutinib In fRail Patients With Previously Untreated Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT04963946. IPD Sharing: NO. Countries: 1. Publications: 0.
Pirtobrutinib and Venetoclax With MRD Detection for Previously Untreated Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT05677919. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.